Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

July 27, 2020

Linda Clark and Brad Gallagher Published on Pharmacy Insider Blog

Linda Clark, Health Care Controversies Team leader, and Brad Gallagher, counsel, recently had their “Caremark’s Bold Move to Restrict Dispensing and Access to Products on the Formulary” article published on the Pharmacy Insider blog.

“Suspect product” lists have been used for years by pharmacy benefit managers (PBMs) to target independent pharmacies and subject them to heightened scrutiny. These lists often target high margin products or other drugs that, for other unknown reasons, may be disfavored by PBMs without regard to formularies of individual plans. The lists are secret, and only “word-of-mouth” through the experiences of other network pharmacies do we learn of the targeted products or manufacturers.”

Read the full article here.

Featured Media

Alerts

Eighth Circuit Rules in Favor of Insurer in First Appellate Decision Involving COVID-19 Business Interruption Coverage

Alerts

American Rescue Plan Act: Initial New York State Spending Plan, New York State Then Subverts Federal Assurances

Alerts

Education Department's Office for Civil Rights Issues Q&A on Title IX Sexual Harassment Regulations

Alerts

New York State Office of Renewable Energy Siting Regulations Challenged by Host Communities and Local Interest Groups

Alerts

New York State Department of Labor Issues HERO Act Guidance

Alerts

US Department of Education Applies Bostock v. Clayton County to Title IX Enforcement

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out